Thiola EC 100 MG tablet 300S
Ended Awarded
- Contract number
- SPE2DB26FX7G2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,087
Award facts
- Contract value 100% obligated
- $6,087.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $6,087.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 300 tablets of Thiola EC 100 mg. This delivery order, issued on November 10, 2025, with an ultimate completion date of December 3, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The place of performance is Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy designed to supply the Department of Defense with comprehensive pharmaceutical products and medical consumables. DMS Pharmaceutical Group holds a single-award IDC valued at $499.999 billion through December 31, 2036, positioning the company as a critical pharmaceutical supplier for military healthcare facilities worldwide. The company has demonstrated substantial federal contracting activity through numerous delivery orders issued by the DLA Medical Supply Chain division, supplying an extensive range of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to support recurring medical supply needs of the DoD healthcare system.
Quick answers
Who was awarded contract SPE2DB26FX7G2?
SPE2DB26FX7G2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FX7G2 worth?
The government has obligated $6,087 on SPE2DB26FX7G2.
Is contract SPE2DB26FX7G2 an order under another contract?
Yes. SPE2DB26FX7G2 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB26FX7G2 competed?
The extent of competition for SPE2DB26FX7G2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award